Abstract
NRAS mutation in melanoma has been associated with aggressive tumor biology and poor prognosis. Although targeted therapy has been tested for NRAS mutated melanoma, response rates still appear much weaker, than in BRAF mutated melanoma. While plenty of cell lines exist, however, only few melanogenic cell lines retain their in vivo characteristics. In this work we present an intensively pigmented and well-characterized cell line derived from a highly aggressive NRAS mutated cutaneous melanoma, named MUG-Mel2. We present the clinical course, unique morphology, angiogenic properties, growth characteristics using in vivo experiments and 3D cell culture, and results of the exome gene sequencing of an intensively pigmented melanogenic cell line MUG-Mel2, derived from a cutaneous metastasis of an aggressive NRAS p. Q61R mutated melanoma. Amongst several genetic alterations, mutations in GRIN2A, CREBP, PIK3C2G, ATM, and ATR were present. These mutations, known to reinforce DNA repair problems in melanoma, might serve as potential treatment targets. The aggressive and fast growing behavior in animal models and the obtained phenotype in 3D culture reveal a perfect model for research in the field of NRAS mutated melanoma.
References
Oct 31, 1970·The Medical Journal of Australia·J A Lee, J M Merrill
Sep 1, 1994·Current Biology : CB·T KodakiP J Parker
Aug 18, 1994·Nature·P Rodriguez-VicianaJ Downward
Jan 2, 2003·Nature Reviews. Cancer·Julian Downward
Feb 21, 2003·International Journal of Cancer. Journal International Du Cancer·Keiran S M Smalley
Dec 24, 2004·Journal of Cell Science·Matthew J O'Connell, Karlene A Cimprich
May 19, 2005·Cancer Research·Julien AckermannFriedrich Beermann
Oct 5, 2006·Cancer Research·Nicolas DumazRichard Marais
Feb 25, 2009·Nature Reviews. Cancer·Marcos Malumbres, Mariano Barbacid
Dec 18, 2009·Nature·Erin D PleasancePeter J Campbell
Apr 19, 2011·Nature Genetics·Xiaomu WeiYardena Samuels
May 28, 2011·Pigment Cell & Melanoma Research·Bianca DevittGrant McArthur
Sep 29, 2011·Nature Genetics·Todd D PrickettYardena Samuels
Jul 24, 2012·Cell·Eran HodisLynda Chin
Feb 19, 2013·The Lancet Oncology·Paolo A AsciertoReinhard Dummer
Aug 8, 2013·Cancer·Amanda D BucheitMichael A Davies
Nov 6, 2013·Stem Cells and Development·Yan-Ru LouMarjo Yliperttula
Jan 29, 2014·European Journal of Cell Biology·Manfred Kunz
Apr 5, 2014·Biomaterials·Melina M MalinenArto O Urtti
Oct 4, 2014·Oncotarget·Igor VujicSusana M Ortiz-Urda
Apr 28, 2010·Pharmaceuticals·Jill M Wagner, Scott H Kaufmann
Citations
Sep 25, 2019·Stem Cell Research & Therapy·Jasmi KiiskinenRaili Koivuniemi
Nov 2, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Christin DurchscheinNadine Kretschmer
May 16, 2019·Scientific Reports·Riina HarjumäkiMonika Österberg
Jan 22, 2020·Journal of Natural Products·Alexander StallingerBeate Rinner
Jul 7, 2021·Alternatives to Laboratory Animals : ATLA·Bhumika SinghJohn Malcolm Wilkinson